BACKGROUND: Only a minority of hypertensive individuals is adequately controlled for their hypertension, partially because reliable predictors for efficient antihypertensive drug therapy are lacking. METHODS: In a prospective, randomized, double-blind, cross-over, placebo-controlled study (The GENRES Study), 208 moderately hypertensive Finnish men (aged 35 to 60 years) were treated for 4 weeks with antihypertensive drugs from four different classes: amlodipine (5 mg), bisoprolol (5 mg), hydrochlorothiazide (25 mg), or losartan (50 mg) daily. Each individual received each of the four monotherapies in a randomized order. Four-week placebo periods were included before and between drug treatment periods. Antihypertensive responses were assessed with 24-h ambulatory and office measurements and analyzed according to age, body mass index, triceps skin fold thickness, waist-to-hip ratio, duration of hypertension, number of previous antihypertensive drugs, number of affected parents, and blood pressure (BP) levels, and profiles during placebo periods. RESULTS: The median BP responses in 24-h ambulatory recordings (systolic/diastolic) were 11/8 mm Hg for bisoprolol, 9/6 mm Hg for losartan, 7/5 mm Hg for amlodipine, and 5/2 mm Hg for hydrochlorothiazide. The highest pairwise within-subject correlations in BP responses were seen for the combinations of bisoprolol-losartan and amlodipine-hydrochlorothiazide. The BP responses to bisoprolol and losartan did not vary according to the variables. Amlodipine and hydrochlorothiazide responses were positively correlated with age, placebo BP level, and lower night-time dipping on placebo. CONCLUSIONS: Baseline clinical and BP parameters may be used to predict the efficacy of antihypertensive therapies. The GENRES Study material should provide an excellent platform for future pharmacogenetic analyses of antihypertensive drug responsiveness.
RCT Entities:
BACKGROUND: Only a minority of hypertensive individuals is adequately controlled for their hypertension, partially because reliable predictors for efficient antihypertensive drug therapy are lacking. METHODS: In a prospective, randomized, double-blind, cross-over, placebo-controlled study (The GENRES Study), 208 moderately hypertensive Finnish men (aged 35 to 60 years) were treated for 4 weeks with antihypertensive drugs from four different classes: amlodipine (5 mg), bisoprolol (5 mg), hydrochlorothiazide (25 mg), or losartan (50 mg) daily. Each individual received each of the four monotherapies in a randomized order. Four-week placebo periods were included before and between drug treatment periods. Antihypertensive responses were assessed with 24-h ambulatory and office measurements and analyzed according to age, body mass index, triceps skin fold thickness, waist-to-hip ratio, duration of hypertension, number of previous antihypertensive drugs, number of affected parents, and blood pressure (BP) levels, and profiles during placebo periods. RESULTS: The median BP responses in 24-h ambulatory recordings (systolic/diastolic) were 11/8 mm Hg for bisoprolol, 9/6 mm Hg for losartan, 7/5 mm Hg for amlodipine, and 5/2 mm Hg for hydrochlorothiazide. The highest pairwise within-subject correlations in BP responses were seen for the combinations of bisoprolol-losartan and amlodipine-hydrochlorothiazide. The BP responses to bisoprolol and losartan did not vary according to the variables. Amlodipine and hydrochlorothiazide responses were positively correlated with age, placebo BP level, and lower night-time dipping on placebo. CONCLUSIONS: Baseline clinical and BP parameters may be used to predict the efficacy of antihypertensive therapies. The GENRES Study material should provide an excellent platform for future pharmacogenetic analyses of antihypertensive drug responsiveness.
Authors: Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Amber L Beitelshees; John G Gums; Rhonda M Cooper-DeHoff; Eric Boerwinkle; Julie A Johnson; Kent R Bailey Journal: Am J Hypertens Date: 2010-08-19 Impact factor: 2.689
Authors: Yan Gong; Caitrin W McDonough; Amber L Beitelshees; Nihal El Rouby; Timo P Hiltunen; Jeffrey R O'Connell; Sandosh Padmanabhan; Taimour Y Langaee; Karen Hall; Siegfried O F Schmidt; Robert W Curry; John G Gums; Kati M Donner; Kimmo K Kontula; Kent R Bailey; Eric Boerwinkle; Atsushi Takahashi; Toshihiro Tanaka; Michiaki Kubo; Arlene B Chapman; Stephen T Turner; Carl J Pepine; Rhonda M Cooper-DeHoff; Julie A Johnson Journal: J Hypertens Date: 2015-11 Impact factor: 4.844
Authors: Martina Chittani; Roberta Zaninello; Chiara Lanzani; Francesca Frau; Maria F Ortu; Erika Salvi; Giovanni Fresu; Lorena Citterio; Daniele Braga; Daniela A Piras; Simona Delli Carpini; Dinesh Velayutham; Marco Simonini; Giuseppe Argiolas; Simona Pozzoli; Chiara Troffa; Valeria Glorioso; Kimmo K Kontula; Timo P Hiltunen; Kati M Donner; Stephen T Turner; Eric Boerwinkle; Arlene B Chapman; Sandosh Padmanabhan; Anna F Dominiczak; Olle Melander; Julie A Johnson; Rhonda M Cooper-Dehoff; Yan Gong; Natalia V Rivera; Gianluigi Condorelli; Bruno Trimarco; Paolo Manunta; Daniele Cusi; Nicola Glorioso; Cristina Barlassina Journal: J Hypertens Date: 2015-06 Impact factor: 4.844
Authors: Daniel H Katz; Rahul C Deo; Frank G Aguilar; Senthil Selvaraj; Eva E Martinez; Lauren Beussink-Nelson; Kwang-Youn A Kim; Jie Peng; Marguerite R Irvin; Hemant Tiwari; D C Rao; Donna K Arnett; Sanjiv J Shah Journal: J Cardiovasc Transl Res Date: 2017-03-03 Impact factor: 4.132
Authors: Erika Salvi; Zhiying Wang; Federica Rizzi; Yan Gong; Caitrin W McDonough; Sandosh Padmanabhan; Timo P Hiltunen; Chiara Lanzani; Roberta Zaninello; Martina Chittani; Kent R Bailey; Antti-Pekka Sarin; Matteo Barcella; Olle Melander; Arlene B Chapman; Paolo Manunta; Kimmo K Kontula; Nicola Glorioso; Daniele Cusi; Anna F Dominiczak; Julie A Johnson; Cristina Barlassina; Eric Boerwinkle; Rhonda M Cooper-DeHoff; Stephen T Turner Journal: Hypertension Date: 2016-10-31 Impact factor: 10.190
Authors: F Gueyffier; F Subtil; T Bejan-Angoulvant; Y Zerbib; J P Baguet; J M Boivin; A Mercier; G Leftheriotis; J P Gagnol; J P Fauvel; C Giraud; G Bricca; D Maucort-Boulch; S Erpeldinger Journal: J Hum Hypertens Date: 2014-04-17 Impact factor: 3.012
Authors: Stephen T Turner; Eric Boerwinkle; Jeffrey R O'Connell; Kent R Bailey; Yan Gong; Arlene B Chapman; Caitrin W McDonough; Amber L Beitelshees; Gary L Schwartz; John G Gums; Sandosh Padmanabhan; Timo P Hiltunen; Lorena Citterio; Kati M Donner; Thomas Hedner; Chiara Lanzani; Olle Melander; Janna Saarela; Samuli Ripatti; Björn Wahlstrand; Paolo Manunta; Kimmo Kontula; Anna F Dominiczak; Rhonda M Cooper-DeHoff; Julie A Johnson Journal: Hypertension Date: 2013-06-10 Impact factor: 10.190